Study on immunomodulation and antitumor activity of paeonol in HepA tumor mice

Chinese Pharmacological Bulletin

Volumn 19, Issue 2, 2003, Pages 160-162

  Sun, Guo Ping ^a   Shen, Yu Xian ^a   Zhang, Ling Ling ^a   Zhou, Ai Wu ^a   Wei, Wei ^a   Xu, Shu Yun ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Antitumor; IL 2; Paeonol; TNF

Indexed keywords

INTERLEUKIN 2; PEONOL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOMODULATION; MOUSE; NONHUMAN; RADIOIMMUNOASSAY; SPLEEN CELL;

EID: 0038332153     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Nishimura T, Ohta S, Sato N et al. Combination tumor immunotherpy with recombinant tumor necrosis factor and recombinant interleukin 2 in mice. Int J Cancer, 1987;40(2):255-61
2. Schiller JH, Morgan-Ihrig C, Levitt ML. Concomitant administration of interlenkin-2 plus tumor necrosis factor αin advanced non-small cell lung cancer. Aro J Clin Oncol, 1995;18(1):47-51